Persisting psychological complications following the use of classic psychedelics: A qualitative study of help-seeking experiences

While growing enthusiasm for the therapeutic potential of classic psychedelics has led to a rise in non-clinical use, attention to persisting adverse effects has emerged with delay. A subset of individuals report persisting complications such as hallucinogen persisting perception disorder (HPPD), depersonalization/derealization disorder (DDD), anxiety and depression. Yet few medical services are equipped to address these complications.

This qualitative study examines how societal, medical, and media discourses shape the experiences of individuals with persisting psychedelic-related complications, focusing on help-seeking trajectories.

Thirteen semi-structured interviews with adults experiencing persisting psychedelic-related psychological symptoms (four women, nine men, age 19-49 years; HPPD (n = 10), DDD (n = 6), depression (n = 1), and anxiety (n = 1)) were conducted within a larger study on these complications. All psychedelic index experiences preceding the onset of symptoms occurred in non-clinical, naturalistic settings rather than in controlled clinical or research contexts. Data were analysed using reflexive thematic analysis. Reporting followed the Consolidated Criteria for Reporting Qualitative Research (COREQ) guidelines.

Three interrelated themes emerged: (1) The dissonance between expectation and harm-idealized media and scientific portrayals of psychedelics shaped initial use and complicated recognition of adverse outcomes; (2) stigma, silence, and self-blame-prohibitionist discourse and internalized shame significantly inhibited help-seeking; and (3) between systemic absence and self-organized support-participants encountered clinical unpreparedness and epistemic dismissal, which often led them to rely on online peer communities and self-management strategies. Positive clinical encounters, characterized by professional expertise and non-judgemental engagement, were experienced as helpful.

Adequate clinical and conceptual frameworks for persisting psychedelic-related complications are lacking. An interdisciplinary, experience-informed approach integrating realistic risk communication, clinician training, and destigmatization is required to support affected individuals.